Skip to main content
. 2022 Sep 7;127(9):998–1022. doi: 10.1007/s11547-022-01534-0

Box 2.

Late-onset Alzheimer Disease (Lo-AD)

Generals

 – The most common cause of late-onset (≥ 65 yo) dementia [52]

 – Incidence and prevalence increase with age (growing up because of an aging population) [1]

 – Cerebrovascular disease frequently coexists with AD

 – Cerebral amyloid angiopathy (CAA) can co-occur with AD

 – General neurological examination is substantially normal

 – Neuropsychiatric symptoms are common

Clinical features and diagnosis

Typical presentation:

 – Early and prominent episodic memory loss (recent events) plus

 – Executive, language, and visuospatial impairment

MRI

 – Disproportionate bilateral (or mild asymmetric) temporoparietal cortical atrophy with (early) prevalent involvement of entorhinal cortex/ medial temporal lobes (± hippocampus ┼) and (more later) precuneus ¶ and posterior cingulate gyrus

 – Relative sparing of the primary motor&somatosensory (pericentral) and occipital cortex

FDG-PET: mirrors MRI findings, with gross correspondence between hypometabolic and atrophic areas Δ

Ioflupane-SPECT (DaTscan): normal

Amyloid-PET: abnormal diffuse cortex uptake with loss of gray-white differentiation (cerebellum spared)

τ-PET: hippocampal-body and precuneus abnormal τ uptake in early-stage

Atypical presentation/non-amnestic syndromes (more common in early-onset disease [42]):

 – Visual variant—posterior cortical atrophy (PCA)

 – Logopenic variant primary progressive aphasia (lvPPA)

 – Progressive executive dysfunction

[For clinical overview and imaging findings see Box 3]

Pitfalls:

 – Iron-sensitive sequences should be performed to assess for hemorrhages associated with CAA (see Box 9) [22]

 - SVD associated WMHs frequent coexist with AD findings

┼ Compared to early-onset AD, patients with late-onset disease show greater medial temporal atrophy and less cortical atrophy

The involvement of precuneus is a late feature of lo-ad or an early feature of eo-AD [see Box 3]

Δ Usually the FDG-PET findings correspond to the MRI atrophic changes, but in some cases the molecular findings may be more severe than structural findings